ClinicalTrials.gov
ClinicalTrials.gov Menu

Project TEAM: Teaching HIV Prevention in the HIV Clinic

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00164320
Recruitment Status : Completed
First Posted : September 14, 2005
Last Update Posted : September 14, 2005
Sponsor:
Information provided by:
Centers for Disease Control and Prevention

Brief Summary:
The purpose of this study is to determine if the TEAM prevention intervention delivered by a physician and an HIV-positive counselor is effective. It is hypothesized that those who receive the intervention will report a higher reduction in risky sex than those who were in the standard-care condition.

Condition or disease Intervention/treatment Phase
HIV Behavioral: TEAM Phase 2

Study Type : Interventional  (Clinical Trial)
Enrollment : 600 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Project TEAM: Teaching HIV Prevention in the HIV Clinic
Study Start Date : May 2004
Study Completion Date : May 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources




Primary Outcome Measures :
  1. Self-reported unprotected (without condoms)anal or vaginal sex with HIV-negative or unknown-status persons.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • 1) 18 years or older, 2) HIV-infected, 3) Sexually active, 3)Receiving HIV primary care at participating clinic, 4) Can communicate in English or Spanish, 5) No previous enrollment in the TEAM study or intervention.

Exclusion Criteria:

  • 1) Participation in a similar study run by the TEAM PI.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00164320


Locations
United States, Florida
University of Miami School of Medicine
Miami, Florida, United States, 33136
Sponsors and Collaborators
Centers for Disease Control and Prevention
Investigators
Study Director: Dogan Eroglu, PhD. Centers for Disease Control and Prevention
Principal Investigator: Lisa Metsch, PhD. University of Miami

ClinicalTrials.gov Identifier: NCT00164320     History of Changes
Other Study ID Numbers: CDC-NCHSTP-3699
R18/CCR420971-01
First Posted: September 14, 2005    Key Record Dates
Last Update Posted: September 14, 2005
Last Verified: September 2005